Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Potent, selective, orally active tachykinin NK1 antagonist reported by Menarini

May 15, 1997

RPR and AMRAD initiate collaboration on antiasthmatic natural products

May 14, 1997

Dual H1/NK1 antagonist for allergic rhinitis from HMR

May 14, 1997

MMP inhibitor from British Biotech effective against oxidant-induced lung injury

May 14, 1997

Immunex reports new chemokine-binding protein

May 14, 1997

Dura acquires two intranasal steroid products from Syntex

May 13, 1997

Sequana and Boehringer Ingelheim expand alliance for asthma research

May 12, 1997

Bradykinin antagonists from Fujisawa

May 9, 1997

Kowa/Vrije University researchers identify potent CysLT1 receptor antagonists

May 7, 1997

FDA grants SciClone orphan drug status for CPX

May 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...